In addition to their function in lipid absorption, BAs are signaling molecules that are believed to play a pivotal role in NAFLD via the activation of FXR and Takeda-G-protein-receptor-5 (TGR5). This evidence concerns the gene GPBAR1 and metabolic dysfunction-associated steatotic liver disease.